Physician profile
Jacob Yannetta
NPI 1992873046
$2,449.67
in general payments reported to CMS, 2019-2025
15 companies · $19.48 in 2025
The $19.48 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $693 · 2020: $278 · 2021: $432 · 2022: $768 · 2023: $31.48 · 2024: $228 · 2025: $19.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $279.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $794.67 | 2019-2022 | |
| W. L. Gore & Associates, INC. | $501.10 | 2019-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Excluder Iliac Branch Endoprosthesis |
| Penumbra, INC. | $277.79 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $235.64 | 2020-2023 | Crosser Iq |
| Boston Scientific Corporation | $172.24 | 2021-2022 | |
| Angiodynamics, INC. | $136.12 | 2024 | Angiovac |
| Cook Medical LLC | $82.18 | 2019-2022 | |
| Lemaitre Vascular, INC. | $64.17 | 2024 | Artegraft Vascular Graft |
| Baxter Healthcare | $46.85 | 2020-2022 | |
| Cardiovascular Systems INC. | $44.28 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $30.27 | 2022 | |
| Avanos Medical | $17.19 | 2019 | |
| Medtronic, INC. | $16.75 | 2023 | Abre |
| Siemens Medical Solutions USA, INC. | $16.34 | 2021 | |
| Tactile Systems Technology INC | $14.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Yannetta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.